DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX (Q2147506)

From EU Knowledge Graph
Revision as of 12:45, 25 January 2022 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in es, and other parts: Adding Spanish translations)
Jump to navigation Jump to search
Project Q2147506 in Italy
Language Label Description Also known as
English
DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX
Project Q2147506 in Italy

    Statements

    country
    Italy
    0 references
    EU contribution
    132,201.83 Euro
    0 references
    budget
    178,156.84 Euro
    0 references
    co-financing rate
    74.21 percent
    0 references
    start time
    1 November 2016
    0 references
    expected end time
    31 December 2018
    0 references
    beneficiary name (string)
    UNISALERNO- DIFARMA
    0 references
    beneficiary
    Q265577
    0 references
    coordinate location

    40°44'48.98"N, 14°46'11.96"E
    0 references
    summary
    BIOTECNOLOGIE (Italian)
    0 references
    BIOTECHNOLOGY (English)
    0 references
    BIOTECHNOLOGIE (French)
    point in time
    23 December 2021
    0 references
    BIOTECHNOLOGIE (Dutch)
    point in time
    24 December 2021
    0 references
    BIOTECHNOLOGIE (German)
    point in time
    25 December 2021
    0 references
    BIOTECNOLOGÍA (Spanish)
    point in time
    25 January 2022
    0 references

    Identifiers

    Italian Unique Project Code
    B48I17000350008
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q2147506&oldid=24436440"